Abstract. In this paper we report that the integrin complex alphal/betal, a laminin/collagen receptor, is expressed on cultured foreskin microvascular endothelium, but is absent on endothelial cells from large vessels such as the aorta and umbilical and femoral veins . The restricted expression of integrin alphal/betal to microvascular endothelium was also demonstrated in vivo, by immunohistochemical staining of human tissue sections. Alphal specific antibodies reacted strongly with endothelial cells of small blood vessels and capillaries in several tissues, but not with endothelium of vein and arteries of umbilical cord. Expression of integrin alphal can be induced in cultured umbilical vein endothelial cells by treatment with 5 ng/ml tumor necrosis factor alpha (TNFalpha). Induction of alphal NDOTHE LI ALcells formacontinuous layer covering the blood vessel luminal surface and represent the physical barrier between the blood stream and tissues . The mechanical and functional integrity ofthis barrier is assured by interactions among endothelial cells as well as by their adhesion to the basal membrane, an extracellular matrix structure consisting predominantly of collagen type IV, laminin, nidogen, and heparansulphate . The interaction of endothelial cells with the basal lamina components is mediated by specific cell surface receptors belonging to the integrin family. Integrins are a class of glycoprotein heterodimers of alpha and beta subunits spanning the plasma membrane and connecting the extracellular matrix framework to the intracellular cytoskeletal structures (Ruoslahti and Pierschbacher, 1987; Hynes, 1987; Hemler, 1990) . Endothelial cells from umbilical vein have been shown to express several integrin complexes at their surface. These include the fibronectin receptor (alphal/betal) (Conforti et al ., 1989) , the vitronectin receptor (alpha/beta3) (Cheresh, 1987; Charo et al., 1987; Dejana et al., 1988; Albelda et al., 1990; Throne et al., 1990), as well as three other complexes that function as collagen and laminin receptors (alpha2/betal, alphal/betal, and alpha6/betal) (Albelda et al., 1989; Languino et al., 1989; Throne et al ., 1990). All five integrin complexes are simultaneously expressed by umbilical vein endothelium, endow-9) The Rockefeller University Press, 0021-9525/91/08/855/9 $2 .00 The Journal of Cell Biology, Volume 114, Number 4, August 1991855-863 subunit expression also occurred after treatment of umbilical vein endothelium with 10-5 M retinoic acid or with 10 nM PMA ; Maximal induction of alphal integrin was reached after 48 h of treatment and costimulation with TNFalpha and PMA resulted in a synergistic effect . The induction of alphal integrin changed the adhesive properties of umbilical vein endothelial cells, by increasing the adhesiveness to collagen, laminin, and laminin fragment PI, while adhesion to fibronectin and laminin fragment E8 remained constant . The alphal integrin is thus a marker of a specific population of endothelial cells and its expression confers distinctive properties of interaction with the underlying basal membrane.
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ing these cells with the ability to recognize and adhere to both basal membrane and stromal matrix components. Analysis of umbilical vein endothelial cells exposed to several different inflammatory cytokines and growth factors showed that tumor necrosis factor alpha (TNFalpha)t and interferon gamma (IFNgamma) induce a selective downregulation of specific integrin complexes (Defilippi et al., 1991) , thus indicating that endothelial cells can modulate the integrin profile depending on their functional state.
In this study we show that endothelial cells from different types of blood vessels express different integrin patterns, both in vitro and in vivo. In particular, alphal/betal integrin, known to bind both laminin and collagens, is selectively expressed on endothelial cells from microvasculature, and not on endothelial cells from large vessels such as the aorta and femoral and umbilical veins. Moreover, endothelium from umbilical vein can express integrin alphal/betal when exposed to TNFalpha, retinoic acid, or PMA . The restricted expression of alphal/betal complex and its induction by TNFalpha suggests a specific role of this integrin in endothelial cell function . 
Materials and Methods

Cell Culture and Treatments
Endothelial cells (EC, were isolated by collagenase (Boehringer Mannheim GmBH, Mannheim, Germany) treatment from human umbilical vein according to the method of Gimbrone (1976) . Cells pooled from three to six cords were cultured on gelatin coated 90 mm plastic tissue culture dishes (Falcon Labware, Oxnard, CA), in medium 199 (Flow Laboratories, Irvine, Ayrshire, Scotland) supplemented with 20 % FCS (Flow Laboratories), 100 pg/ml bovine brain extract, 100 14g/ml porcine heparin (Sigma Chemical Co., St . Louis, MO), 100 U/ml penicillin, and 100 Wg/ml streptomycin . The cells were used for the experiments between passages 2 and 6. Human foreskin microvascular EC were isolated as described by Davison et al . (1980) and cultured on fibronectin coated dishes in medium 199 supplemented with 20% human serum, 20 mM Hepes, and penicillin/streptomycin . Primary cultures were incubated for 4 h with Dil (3,3'-dioctadecylindocarbocyanine)-labeled acetylated LDL, subsequently detached from the dish and separated by fluorescence activated cell sorting, as described by Voyta et al . (1984) . After purification the cells were propagated on gelatin coated dishes in M199 medium with 10% human serum, 10% newborn calf serum, 150,ug/ml bovine brain extract, and 100 Wg/ml porcine heparin, 20 mM Hepes, penicillin, and streptomycin . The medium was replaced every 2-3 d . At confluence the cells were divided with a split ratio 1 :2 .5 . The cells were characterized for the presence of von Willebrand factor, the binding of Ulex europeus lectin I, the binding of the endothelium-specific monoclonal antibody Pal-E and the uptake of DiI-acetylated LDL, as previously described (van Hinsberg et al ., 1987a) . Confluent cells between passages 7 and 11 were used for the experiments. Endothelial cells from human aorta and femoral vein were isolated as previously described (van Hinsberg et al ., 1987b) . They were grown on gelatin coated dishes in the same medium as given above . Confluent cells at passage 8 were used for the experiments .
Treatments with the mediators were performed on confluent cultures . Human recombinant tumor necrosis factor alpha (TNFalpha) (1Os cytotoxic U/mg), was a kind gift from Dr. M . Brockhaus (Hoffmann La Roche, Basel, Switzerland) . Human recombinant interferon gamma (IFNgamma) (1Os IU/mg), a kind gift from Dr. G . Garotta (Hoffmann La Roche, Basel, Switzerland), was used at 100 IU/ml . Human recombinant interleukin 6 (IL-6) (2 x 108 IU/mg), a kind gift from Dr. J. Content (Institut Pasteur du Brabant, Bruxelles, Belgium), was used at 5 ng/ml . Human recombinant IL-bbeta (Immunex Corp ., Seattle, WA) (5 x 10' IU/mg) and granulocyte colony stimulating factor (G-CSF) (10' IU/mg) (Bachem Feinchemikalien AG, Bubendorf, Switzerland) were used at 5 ng/ml and 1,000 U/rnl, respectively. Retinoic acid and PMA were from Sigma Chemical Co. During treatment the medium was changed every day. All the treatments of EC were
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Antibodies and Immunoprecipitation ofIntegrins
The polyclonal antibody to the human fibronectin receptor (FN-R), was prepared by immunizing a goat with affinity-purified fibronectin receptor from human placenta (Pytela et al ., 1985) . The antiserum was previously characterized and shown to react with both betal and alphas subunits (Conforti et al ., 1989 ; Throne et al ., 1990) . Its reactivity with betal allows the identification of all receptors of group 1 integrins . The polyclonal antisera to the betal, alpph3, and alphas integrin subunits were prepared in our laboratory by immunizing rabbits against synthetic peptides reproducing amino acid sequences from the cytoplasmic domains of each subunit . The following peptides, obtained from Multiple Peptide System (San Diego, CA), were used : betal, CTTVVNPKYEGK; alpha3, CRIQPSETERLTDDY alphas, KRSLPYGTAMEKAQLKPPATSDA. Peptides were coupled to hemocyanin with glutaraldehyde (approximate peptide to carrier molar ratio of 50 :1) and rabbits were injected with 500 ug of the conjugate in complete Freund adjuvant. Antibodies reacted specifically with the peptide sequence used for immunization as determined by ELISA assay on peptide-BSA conjugates. The antibodies were specific to the appropriate subunit and did not show cross-reaction with other integrin subunits as demonstrated by immunoprecipitation assays on different cell lines .
Mouse monoclonal antibodies to human integrin alphal (mAb TS2/7) and to integrin betal (mAb AIA5) were a kind gift from Dr. Martin Hemler (Dana-Farber Cancer Institute, Boston, MA) . The monoclonal antibody NKI-M9 to integrin alphaV subunit, the monoclonal antibody IOGI l to integrin alpha2 and the monoclonal antibody GOH3 to integrin alpha6 subunit were kind gifts from Dr. A . Sonnenberg (Central Laboratory of the Netherlands Red Cross, Amsterdam, The Netherlands) . Since the integrin alpha/beta complexes are not dissociated under the experimental conditions used, antibodies, although specific for one subunit, immunoprecipitate both of them .
Umbilical vein and microvascular EC were grown at confluence, treated as indicated and metabolically labeled with [33S]methionine or surface labeled with i2'I . [3 sS]Methionine labeling was performed by overnight incubation in methionine-free medium (Flow Laboratories) with 5 % serum and 40,uC/ml of ["S]methionine (800 Ci/mM ; Amersham International) in the presence of the mediators . I'll labeling was performed as described previously (Rossino et al ., 1990) . Briefly, cells were released from culture dishes by 5 mM EDTA treatment in PBS and washed three times by centrifugation with culture medium . Cells were resuspended in PBS containing CaC12 (1 mM) and MgC12 (1 mM) and labeled with 1 MCi of 125 1 in the presence of lactoperoxidase (200 14g/nil) and H202 (0.002%) . To analyze integrins from cell extracts, labeled cells were washed with cold PBS and the cells were extracted for 20 min at 4°C with 0.5 % Triton X-100 (BDH Chemicals Ltd ., Essex, England) in 20 mM Tris-HCI pH 7.4, 150 mM NaCI (TBS) with 1 mM CaCI2, 1 MM M9C12, 10 jig/nil leupeptin, 4 Ag/ml pepstatin, and 0 .1 TIU/ml aprotinin (all from Sigma Chemical Co .) After centrifugation at 10,000 g for 10 min, extracts were incubated with the specific antibodies for 1 h at 4°C with gentle agitation . Soluble immunocomplexes were bound to protein A-Sepharose beads (Pharmacia, Uppsala, Sweden) and recovered by centrifugation . After washing, bound material was eluted by boiling beads in 1% SDS (Pierce Chemical Co ., Rockford, IL), analyzed by 6% SDS-PAGE (Laemmli, 1976) , and fluorographed (Chamberlain, 1979) .
Immunoperoxidase Procedure
Immunohistochemical stainings were performed using the peroxidase anti-peroxidase (PAP) procedure (Sternberger et al ., 1970) . Muscle tissue was obtained by quadriceps biopsies of adult subjects with normal histological pattern . Umbilical cords were obtained from the delivery room of the local hospital . Dermis samples were obtained by skin biopsies from volunteer healthy donors . Histologically normal parts of brain and kidney were obtained by surgery from patients with brain or renal cancer and immediately frozen.
Cryostat sections (7 um) were fixed with acetone for 5 min at -20°C, and treated with 3 % H202 for 5 min at room temperature to block endogenous peroxidase . Sections were incubated overnight at 4°C with optimal dilution of the primary antibody followed by 30 min at room temperature with the secondary antibody. Antibodies to synthetic peptides were affinity purified on BSA-peptide conjugates coupled to Sepharose and used at concentrations ranging from 1 to 10 ug/ml . Samples were then incubated with peroxidase anti-peroxidase complex (Sigma Chemical Co .) and the reaction was developed with diaminobenzidine tetrahydrochloride (0.05%) .
Adhesion Assay
Fibronectin was purified from human plasma by affinity chromatography on gelatin-Sepharose as previously described (Engvall and Ruoslahti, 1977 ; Throne et al ., 1982) . Laminin from EHS tumor and its cell binding fragments PI and E8 were a kind gift of Dr. R. Timpl (Max Planck Institut fur Biochemie, Martinsried, Germany) . Collagen type IV was from Sigma Chemical Co. Adhesion assay was performed as described previously (Defilippi et al ., 1991) . 96-well microtiter dishes (Costar, Cambridge, MA) were coated with optimal concentrations of various substrates and postcoated with BSA (Eurobio, Paris, France) . Cells were released from culture dishes by gentle 5 mM EDTA treatment in PBS and plated in serum-free DMEM medium (Flow Laboratories) on coated wells for different times at 37°C. To eliminate the contribution of protein synthesis and secretion in cell adhesion, cells were pretreated 2 h before detachment with the protein synthesis inhibitor cycloheximide (20 mM) (Sigma Chemical Co.), and plated in the adhesion assay in the presence of 1 uM monensin (Sigma Chemical Co.) and 20 uM cycloheximide. Cell adhesion was evaluated by a colorimetric assay for acid phosphatase activity, by modifying the method described by Connolly et al . (1986) . Adherent cells were washed two times with PBS, and acid phosphatase activity in each well was measured by incubating cells for 90 min at 37°C, in the presence of 200 ul of 10 mMp-nitrophenyl phosphate (Sigma Chemical Co.), 0.1% Triton X-100, 0.1 M sodium acetate, pH 5.5. The colorimetric reaction was developed by adding 20 ul of 1 N NaOH .
The optical absorbencies at 405 run were read with a Microplate Reader (BioRad 450; Bio-Rad Laboratories, Richmond, CA) . A preliminary experiment showed that the optical density was linearly correlated with the number of viable cells.
AlphallBetal Integrin Is Expressed on Microvascular but Not on Large Vessel Endothelium in Culture
Integrin complexes of human foreskin microvascular EC were immunoprecipitated with antibodies to the FN-R which react predominantly with the betal subunit (Throne et al., 1990) . As shown in Fig . 1 A (lane b) these antibodies precipitate the beta subunit (120 kD) as well as associated alpha subunits that are resolved in two bands with molecular masses of 180 and 160 M The fourth band of 100 kD represent an immature form of the betal subunit as determined by pulse-chase experiments (Defilippi, P., and G . Throne, unpublished data ; Heino et al., 1989) . The coprecipitation of alpha subunits with betal antibodies is due to association of these molecules in noncovalent complexes at the cell surface (Ruoslahti and Pierschbacher, 1987; Hynes, 1987; Hemler, 1990 ) . The integrin pattern described above is identical to that of umbilical vein EC (Fig . 1 A, lane a) except for the 180-kD band which is unique to microvascular EC. This molecule has a molecular mass corresponding to that of the alphal subunit (Hemler, 1990) . To more precisely identify this component, as well as the other alpha subunits that comigrate in the 160-kD band, antibodies specific for each known alpha subunit were used . As shown in Fig . 1 (Fig . 3) Immunohistochemical staining of human skeletal muscle tissue sections with antibodies to integrins. Frozen sections of striated skeletal muscle tissue were incubated with alphal monoclonal antibody TS2/7 (a, b, d, and f), with betal monoclonal antibody AIA5 (c and e) or with polyclonal antibodies to von Willebrand factor (g), followed by the appropriate secondary antibodies
The Journal of Cell Biology, Volume 114, 1991 85 8 a) the 180-kD subunit is recognized by alphal-specific monoclonal antibodies . In addition, microvascular EC also express alpha2, alpha3, alpha5, alpha6, and alphaV ( Fig . 1 B,  lanes bf) . A1phaV subunit associates with beta3 to form the vitronectin receptor, while the other alphas are all associated with betal . Preliminary experiments showed that EC do not express alpha4 subunit and this antibody was thus omitted from the panels in Fig . 1 . The use of alpha subunit specific antibodies confirmed the absence of alphal subunit from umbilical vein EC (Fig . 1 C,  lane a) . These cells, like microvascular EC, express alpha2, alpha3, alpha5, alpha6, and alphaV (Fig . 1 C) . Quantitative differences were detected in the relative amount of alpha3 and alpha6 subunits between the two EC types : while alpha3 is abundant in microvascular EC, it is only poorly expressed in umbilical vein endothelium ; the opposite is true for alpha6.
To determine whether the lack of expression of alphal integrin was a property unique to endothelium from umbilical vein, we also analyzed EC isolated from human aorta and femoral vein . As shown in Fig . 2 , these EC do not express the alphal subunit and display an integrin pattern similar to that of umbilical vein EC . Thus, the lack of alphal expression is typical of various large blood vessels.
Alphal Integrin Is Expressed in Microvascular, but Not in Umbilical Vessel Endothelium In Situ
To test whether the differential expression of alphal integrin described above was also detectable in situ, we stained frozen human tissue sections with alphal integrin specific antibodies . As shown in Fig. 3 (a, b, d , and f), the antibodies intensely stained capillaries as well as vessels with larger diameters (50-150 Am) . These structures were also positive with integrin betal antibodies (Fig . 3, c and e) . In addition to skeletal muscle (Fig . 3) capillaries and small vessels in the dermis, kidney, and brain were also positive for both alphal and betal antibodies .
Different results were obtained with endothelium from umbilical cord sections . As shown in Fig . 4 (d-g) , the endothelial layer of umbilical vein and arteries was negative for alphal integrin antibodies, while the underlying smooth muscle cells of the vessel wall were strongly positive. Similar sections were also stained with betal antibodies. In this case, strong positive reaction was visible in the endothelial layer as well as in the underlying smooth muscle (Fig . 4, a-c) . These data fully confirmed the results observed with in vitro cultured EC. Umbilical Vein EC ExpressAlphal Integrin When Exposed to TNFalpha, Retinoic Acid, or PMA To test whether large vessel endothelium can be induced to express alphal integrin, umbilical vein EC were exposed to various treatments in vitro. As shown in Fig. 5 (lane b) , exposure of the cells to TNFalpha resulted in synthesis of alphal subunit . Other inflammatory cytokines and growth factors, including IL-lbeta, IFNgamma, IL-6, G-CSF, and bFGF, were inactive (Fig . 5) , indicating a rather specific effect of TNFalpha. When screening several compounds for their ability to affect alphal integrin expression, we found that, in addition to TNFalpha, retinoic acid and the tumor promoter PMA were also active (Fig . 5, lanes g and h) . PMA followed rather slow kinetics as the protein was appreciable at 24 h and reached maximal levels after 48-72 h of treatment (Fig. 6) . Expression of alphal remained constant in the presence of the mediators for at least 120 h. A dose-response analysis was performed with the three active agents at 48 h of treatment . Retinoic acid was used from 10-°to 10-9 M, and the response reached maximal levels at 10-5 M . TNFalpha was used between 0.1 and 50 ng/ml and the response reached a plateau at 5 ng/ml . PMA was used at concentrations between 0.5 nM and 1 uM, and the optimal dose was found to be 10 nM . When PMA was used at concentrations above 500 nM, a progressive decrease in alphal induction was observed, without any toxic effect on cell viability, as measured by methionine incorporation in TCAprecipitable materials . The level of induced alphal subunit in umbilical vein EC treated with optimal doses of TNFalpha or PMA, was comparable to that found in microvascular EC. Retinoic acid was slightly less potent compared with TNFalpha and PMA . To identify a possible cooperation between the active mediators, combined treatments were tested . As shown in Fig . 7 , when suboptimal doses were used, a synergistic induction of alphal subunit was observed in cells costimulated with PMA and TNFalpha or PMA and retinoic acid . The induced alphal subunit was exposed at the cell surface, as indicated by immunoprecipitation of surface iodinated cells (Fig . 8, lanes b and d) .
Alphal Integrin Expression Increases Adhesiveness of Umbilical Vein EC
To test whether the described induction of alphal integrin on umbilical vein EC has any effect on the adhesive properties of these cells, adhesion experiments were performed . The adhesive response of umbilical vein EC treated for 48 h with retinoic acid were compared to that of untreated cells . Retinoic acid was chosen to induce alphal, because TNFalpha and PMA treatments induced modifications of expression of other integrin complexes, besides alphal, and this could complicate the interpretation of the results (Defilippi, P., and G. Throne, unpublished data) . As shown in Fig . 9 , retinoic acid-treated EC showed increased adhesion to microtiter plates coated with collagen IV (a), and laminin (b), while they retained normal adhesion to fibronectin (d) . When cells wereplated on laminin fragments Pl and E8, treated cells adhered faster to PI fragment compared to untreated cells, while they behaved similarly on E8 fragment (Fig . 9 c) . These data are consistent with the ligand specificity of alphal/betal integrin (Ignatius and Reichardt, 1988 ; Kramer and Marks, 1989; Rossino et al ., 1990; Hall et al ., 1990) .
Discussion
The data reported in this paper show that integrin alphal/ betal is selectively expressed by EC from microvasculature but not from large blood vessels such as the aorta, femoral vein, and umbilical arteries and vein. Moreover, the expression of this integrin can be induced in large vessel endothelium by the inflammatory cytokine TNFalpha as well as by other selected agents . Expression of alphal/betal seems to be a general property of microvascular endothelium in different tissues . We have detected positive capillary and microvascular endothelium in skeletal muscle, foreskin, dermis, brain, and kidney. Alphal positive capillary endothelium in dermis, brain, and kidney has also been reported by others (Konter et al ., 1989 ; McGeer et al ., 1990 ; Korhonen et al ., 1990) . The strong staining of microvascular endothelium in situ also excluded the possibility that synthesis and expression of alphal subunit in cultured microvascular EC was due to artifacts or contamination of cell culture . At the same time, lack of alphal integrin on EC from large vessels also seems to be a general property. Negative results were obtained on cultured cells from aorta, femoral vein and umbilical vein, and absence of alphal in both arteries and veins was confirmed by tissue staining of the blood vessels in the umbilical cord . Thus our results demonstrate that alphal/betal integrin clearly labels only EC in microvasculature .
The absence of alphal/betal complex in large vessel EC is not a constitutive property, since we show that different mediators can induce alphal integrin expression in umbilical vein EC . Among those tested, the inflammatory cytokine TNFalpha, the tumor-promoter PMA, and retinoic acid were found to be active . Retinoic acid is a naturally occurring morphogen involved in tissue differentiation and pattern formation during vertebrate development (Brockees, 1989) . It is thus possible that retinoic acid affects endothelial cell function during development and its ability to induce alphal integrin in these cells should probably be considered in the context of its morphogenic activity. neuroblastoma and teratocarcinoma cell lines (Rossino, P., and G. Throne, unpublished results) , thus indicating that this integrin alpha subunit is upregulated by retinoic acid in several cell types . A second stimulus for alphal subunit induction is TNFalpha, a well characterized cytokine that causes several biochemical and morphological changes in EC in response to inflammatory stimuli (Pober, 1988) . In particular TNFalpha increases expression of class I histocompatibility antigens (Collins et al ., 1986 ; Lapierre et al ., 1988) and of three adhesive proteins, ICAM-1 , ELAM-1 Bevilacqua et al ., 1987) , and VCAM-1 (Osborn et al ., 1989) . The modulation of the latter proteins and of alphal integrin by TNFalpha differs by several criteria . Maximal levels of alphal integrin are reached after 48 h of TNFalpha treatment, while maximal expression of ICAM-1 and VCAM-1 occurs within 20 h Osborn et al ., 1989) and within 6 h for ELAM-1 Bevilacqua et al ., 1987) . Furthermore, induction of ELAM-1 is transient as the levels of the molecule decline after 6-8 h of exposure to TNFalpha despite the continuous presence of the cytokine, while the alphal subunit remains constant over the time period measured (120 h) . The kinetics of induction of alphal integrin is comparable to that observed for the induction of class I major histocompatibility antigens (Collins et al ., 1986) and indicates that these two molecules have a role in later stages of the inflammatory response, as compared with ICAM-1, VCAM-1, and ELAM-1 . The latter three molecules are located at the apical surface of endothelial cell, and mediate adhesion of leukocytes to the vessel wall at inflammatory sites. The alphal/betal integrin is likely to be located on the basal surface of the cells to mediate interaction with basal lamina. The pathway of intracellular signaling that leads to modulation of alphal integrin expression is likely to involve activation of protein kinase C (Castagna et al., 1982; Nishizuka, 1984) . This is suggested by the fact that low doses of PMA (10 nM), known to activate protein kinase C (Nishizuka, 1984) , induce the expression of alphal integrin. The activation of protein kinase C has been implicated in the signal transduction by TNFalpha in several cell types (Johnson and Baglioni, 1990; Schutze et al., 1990) . In line with this we found that PMA potentiates the effect ofTNFalpha on alphal induction, when the two agents are administered simultaneously. Furthermore, treatment of umbilical vein EC with doses of PMA above 500 nM, known to deplete cells ofprotein kinase C activity (Adams and Gullick, 1989 ), results in a decreased level of induction of alphal integrin .
We have previously shown that treatment of umbilical vein EC with a combination of both TNFalpha and IFNgamma alters the expression of the vitronectin receptor (integrin beta3) (Throne et al., 1990; Defilippi et al., 1991) . In this case the two cytokines caused a downregulation of this receptor by specifically affecting the synthesis of the beta3 subunit . A third integrin complex, alpha6/betal, is downregulated by TNFalpha (Defilippi, P , and G. Throne, unpublished results) , thus showing that alteration of the endothelium-matrix interactions is likely to play an important role in the vascular response during inflammation .
Integrin alphal/betal is expressed on several cell types and binds both collagens and laminin (Ignatius and Reichardt, 1988 ; Kramer and Marks, 1989; Turner et al ., 1989; Rossino et al., 1990; Hall et al., 1990) . Recently Kramer et al. (1990) reported the expression of alphal/betal integrin in microvascular EC and showed that this receptor can bind laminin . Moreover, previous data indicate that the interaction of EC with laminin and collagens involves multiple receptors, including alpha2/betal, alpha3/betal, alpha6/ betal, and alpha/beta3 Kramer et al., 1990) , and the precise role of each of them is not yet determined. An interesting functional property of the alphal/ betal integrin is its ability to bind to a laminin region distinct from that recognized by other integrin complexes . Laminin structure has been extensively investigated using the protein produced by the mouse EHS tumor. This protein is a crossshaped molecule of 900 kD, consisting of three polypeptide chains, A, Bl, and B2 (Timpl, 1989) , and can be split into two major fragments by proteolysis . These are the E8 fragment, obtained by elastase digestion and corresponding to the lower portion of the long arm of the cross (Paulsson et al ., 1985) , and the Pl, or El, fragment, obtained by either pepsin or elastase digestion, and corresponding to the central region of the molecule at the junction of the three short arms (Timpl, 1989) . The three laminin receptors, alpha2/ betal, alpha3/betal, and alpha6/betal all bind to the long arm region (Fragment E8) (Languino, L., and E. Ruoslahti, personal communication ; Gehlsen et al., 1989; Sonnenberg et al., 1990; Hall et al., 1990) , while the binding site of the recently identified laminin binding alpha/beta3 complex (Kramer et al., 1990) has not yet been mapped . The alphal/ betal receptor, on the other hand, binds to the central cross region of laminin (PI fragment) (Hall et al ., 1990; Rossino et al., 1990) . In agreement with the binding specificity, we
The Journal of Cell Biology, Volume 114, 1991 found that expression of alphal integrin on umbilical vein EC, potentiates the adhesion ofEC to collagen, laminin, and laminin fragment P1, but not to laminin fragment E8 or to fibronectin . It is also possible that the alphal/betal receptor recognizes a specific laminin isoform different from the A, BI, B2 molecule used in our experiments . In fact, in addition to the mouse EHS laminin, different isoforms of the molecule have been described, with distinct subunit composition and tissue distribution (Edgar et al ., 1988; Leivo and Engvall, 1988; Hunter et al ., 1989) . These isoforms, however, are not yet available in pure form for experimental test.
The adhesive behavior of alphal-expressing EC may be functionally important under specific circumstances, such as angiogenesis (new blood vessel formation) . TNFalpha and PMA, that induce alphal expression, were also found to stimulate angiogenesis in an in vitro assay where endothelial cells are induced to penetrate a three-dimensional collagen gel (Leibovich et al., 1987; Montesano and Orci, 1987) . Angiogenetic stimuli should induce several biochemical changes in endothelium, including proliferation, cytoskeletal assembly and protease secretion. During this process, EC should switch from a stationary to a migratory behavior and it is quite likely that such transition in adhesive properties requires changes of integrin expression such as those described here and in previous work (Defilippi et al ., 1991) .
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